Clearly visible results.
Acanya is clinically proven to treat both inflammatory and non-inflammatory lesions
Results from two double-blind, randomized, controlled studies of Acanya Gel in patients with moderate to severe acne
35% of subjects in clinical trials had at least a 2-grade improvement in Evaluator’s Global Severity Score (EGSS)** with Acanya at week 12 (vehicle 17%)
**EGSS grades are defined as: 0=clear; 1=almost clear; 2=mild; 3=moderate; 4=severe; 5=very severe.
Discontinuation is recommended if significant diarrhea, bloody diarrhea, severe abdominal cramping, or colitis (including pseudomembranous colitis) develops. Clindamycin taken orally or through IV may result in severe colitis, which may result in death.